Short answer: a filler adds volume from the outside; a biostimulator makes your body produce it. A hyaluronic acid filler occupies space where it is injected and creates the shape immediately. A biostimulator instead leaves behind a material that the tissue responds to by producing its own collagen, so the result appears over weeks. Filler is therefore a shaping treatment, while a biostimulator is about tissue quality and overall support.
The strength of filler is control. Millimetre-level goals — volume in the lips, smoothing a transition under the eye, projection at the chin, a defined highpoint on the cheekbone — are worked with filler. The result is visible the same day and, if you are unhappy, it can largely be reversed with hyaluronidase. That reversibility is filler's most important safety feature. See lip filler, tear trough filler and jawline filler for examples.
Biostimulators fall into three main groups, and they are not interchangeable. Radiesse, based on calcium hydroxylapatite (CaHA), gives both immediate volume and collagen stimulation — it behaves as a hybrid. Sculptra and Lanluma, based on poly-L-lactic acid (PLLA), give no immediate volume and are used for gradual volume restoration across larger areas. Juvelook and Lenisna, based on poly-D,L-lactic acid (PDLLA), work in a more superficial plane; their target is not volume but skin texture, fine lines and thinned skin quality. Our biostimulator overview compares the groups in detail.
The practical answer to "which one suits me" is this: if you can stand in front of a mirror and point to a specific spot and say "this area has hollowed", filler. If you say "my face looks generally tired and thinner, I cannot point to one place", biostimulator. If surface crepiness and pore texture bother you, the PDLLA group; if there is broad volume loss, the PLLA group; if contour and structural support are missing, CaHA. In most plans these are complementary rather than alternatives, and are carried out in separate sessions.
Limits: biostimulators do not tighten sagging skin, do not remove excess skin and do not replace surgery. With advanced sagging, post-weight-loss laxity or genuine skin excess, the right option may be a surgical facelift. Unlike filler, biostimulators cannot be dissolved and reversed with an enzyme, which makes over-treatment a serious mistake. Expression lines caused by muscle movement are the domain of neither — those belong to botulinum toxin treatment. Active infection, pregnancy and breastfeeding, known hypersensitivity, a tendency to keloid scarring and some autoimmune conditions may restrict treatment.
Results vary from person to person with skin thickness, age, tissue response, smoking and sun exposure; neither longevity nor a specific outcome can be guaranteed. Which group is used, in which plane and over how many sessions can only be determined by a medical consultation.